Loading patent…
AssigneeZaidan Hojim Biseibutsu Kagaku Kenkyu Kai
InventorsHamao Umezawa, Toshiharu Nagatsu, Tomio Takeuchi, Hajime Morishima, Yoshio Sawasaki, Hiroshi Takezawa, Fujinori Sasaki
Estimating the term…
As new compounds are now provided N-methyl-3-(3,4-dihydroxyphenyl)serine alkyl esters which are effective as an .alpha.-adrenergic and .beta.-adrenergic agent to stimulate the .alpha.-adrenergic and .beta.-adrenergic functions of the central nervous system of mammalian animals and are expectable to be useful for therapeutic treatment of disorders as invoked by reduced biological activities or functions of the .alpha.- and/or .beta.-adrenergic neurons. N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine (C.sub.1 -C.sub.6) alkyl esters are preferred amongst the new compounds of this invention.
An N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine methyl ester or ethyl ester or a pharmaceutically acceptable acid addition salt thereof.
N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine methyl ester.
N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine ethyl ester.
An .alpha.-adrenergic and .beta.-adrenergic agent comprising an N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine (C.sub.1 -C.sub.2) alkyl ester or a pharmaceutically acceptable acid addition salt thereof as the active ingredient in an amount effective to stimulate both the .alpha.-adrenergic and .beta.-adrenergic functions of the central nervous system of mammalian animals, in association with a pharmaceutically acceptable carrier for the active ingredient.
A method of stimulating both the .alpha.-adrenergic and .beta.-adrenergic functions of the central nervous system of a mammalian animal, which comprises administering orally, intravenously, intraperitoneally or rectally to said animal an effective amount of N-methyl-L-threo-3-(3,4-dihydroxyphenyl) serine methyl ester or ethyl ester or a pharmaceutically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.